Zhejiang Huanchou Machinery Equipment Co., Ltd.’s annual production capacity of 1,000 syringe assembly line machines industrialization project is progressing steadily as planned. Located in Caozhai Town, Jindong District, Jinhua City, the project has a total construction area of 45,807 square meters and a building footprint of 8,188 square meters, with construction primarily including three new factory buildings and a processing center. Currently, the main structure has been fully topped out, and workers are conducting interior wall masonry work. The project is expected to be fully operational by the end of the year. Through process innovation and technological upgrades, the project will develop and launch products including disposable syringe automatic assembly machines, self-destructive syringe assembly machines, automatic circular screen printing machines, and syringe automatic rolling printing machines, further enriching Huanchou Machinery’s product portfolio and promoting iterative upgrades in the local pharmaceutical and health industry. Upon completion, the project is expected to generate an annual output value exceeding RMB 300 million, significantly enhancing Huanchou Machinery’s production capacity and delivery capability in the syringe automation equipment sector, providing more efficient and higher-quality medical equipment solutions to global customers.

Zhejiang Huanchou Machinery Equipment Co., Ltd. continues to deepen its presence in the medical device automation field and has recently achieved new breakthroughs in core technology R&D. The company’s self-developed “Rolling Printer Feeding Assembly” has been granted a utility model patent by the China National Intellectual Property Administration. This patented technology enables rapid switching of needle tube conveyance by providing two specifications of card slots on the feeding tray. During production, switching between the first and second types of card slots is fast and convenient, significantly improving production efficiency. Particularly for small-batch orders, it enables rapid response, better meeting customers’ diverse production needs. To date, Huanchou Machinery holds 47 patents, fully demonstrating its technological expertise and innovation capabilities in the medical device automation equipment sector. The company stated that it will continue to pursue an innovation-driven strategy, increase R&D investment, and bring more high-tech medical equipment products to the market.

As the “15th Five-Year Plan” identifies the integration of artificial intelligence with medical equipment innovation as a key priority, the medical device intelligent manufacturing sector is ushering in a new wave of technological transformation. At recent industry exhibitions, multiple equipment manufacturers showcased the application of industrial AI in medical automation production lines. For insulin pens, auto-injectors, and other drug delivery devices, next-generation intelligent production lines have achieved high-speed cam-driven assembly combined with real-time AI monitoring, with production cycles reaching 1.5 seconds per unit, while industrial AI systems enable full-process visualized management of equipment operating status and key process parameters. Industry experts note that as centralized procurement policies continue to advance and the localization process in China’s medical device industry accelerates, the sector is imposing higher requirements on production equipment in terms of machining precision, flexible production capacity, and full-process traceability. Against this backdrop, companies with cross-industry technical expertise and intelligent equipment R&D capabilities are accelerating the migration of mature automation technologies from fields such as automotive manufacturing to the medical equipment sector, driving the industry toward a new development phase characterized by technology convergence, professional compliance, and global service capabilities.

As the localization process in China’s medical device industry continues to deepen, market demand for high-end medical device core components and automated production equipment is showing rapid growth. In segments such as syringes, insulin pens, and medical consumables, the process precision and production efficiency of automated assembly equipment are continuously improving. Some leading equipment manufacturers have achieved technological breakthroughs in micron-level precision assembly, flexible production, and full-process quality control, providing solid support for high-quality large-scale production by medical companies. Meanwhile, sterile unmanned factories are gradually becoming the industry standard. Exploration of fully automated “end-to-end” production of high-end medical device core components such as CT detectors has achieved a first-pass yield of 97%, with delivery cycles significantly shortened. Industry insiders believe that as automation and AI technologies are more deeply applied in medical manufacturing, large-scale, standardized production of domestic medical devices will reach new heights, laying a solid foundation for Chinese medical equipment to enter global markets.

Zhejiang Huanchou Machinery Equipment Co., Ltd.’s annual production capacity of 1,000 syringe assembly line machines industrialization project is progressing steadily as planned. Located in Caozhai Town, Jindong District, Jinhua City, the project has a total construction area of 45,807 square meters and a building footprint of 8,188 square meters, with construction primarily including three new factory buildings and a processing center. Currently, the main structure has been fully topped out, and workers are conducting interior wall masonry work. The project is expected to be fully operational by the end of the year. Through process innovation and technological upgrades, the project will develop and launch products including disposable syringe automatic assembly machines, self-destructive syringe assembly machines, automatic circular screen printing machines, and syringe automatic rolling printing machines, further enriching Huanchou Machinery’s product portfolio and promoting iterative upgrades in the local pharmaceutical and health industry. Upon completion, the project is expected to generate an annual output value exceeding RMB 300 million, significantly enhancing Huanchou Machinery’s production capacity and delivery capability in the syringe automation equipment sector, providing more efficient and higher-quality medical equipment solutions to global customers.

Zhejiang Huanchou Machinery Equipment Co., Ltd. continues to deepen its presence in the medical device automation field and has recently achieved new breakthroughs in core technology R&D. The company’s self-developed “Rolling Printer Feeding Assembly” has been granted a utility model patent by the China National Intellectual Property Administration. This patented technology enables rapid switching of needle tube conveyance by providing two specifications of card slots on the feeding tray. During production, switching between the first and second types of card slots is fast and convenient, significantly improving production efficiency. Particularly for small-batch orders, it enables rapid response, better meeting customers’ diverse production needs. To date, Huanchou Machinery holds 47 patents, fully demonstrating its technological expertise and innovation capabilities in the medical device automation equipment sector. The company stated that it will continue to pursue an innovation-driven strategy, increase R&D investment, and bring more high-tech medical equipment products to the market.

As the “15th Five-Year Plan” identifies the integration of artificial intelligence with medical equipment innovation as a key priority, the medical device intelligent manufacturing sector is ushering in a new wave of technological transformation. At recent industry exhibitions, multiple equipment manufacturers showcased the application of industrial AI in medical automation production lines. For insulin pens, auto-injectors, and other drug delivery devices, next-generation intelligent production lines have achieved high-speed cam-driven assembly combined with real-time AI monitoring, with production cycles reaching 1.5 seconds per unit, while industrial AI systems enable full-process visualized management of equipment operating status and key process parameters. Industry experts note that as centralized procurement policies continue to advance and the localization process in China’s medical device industry accelerates, the sector is imposing higher requirements on production equipment in terms of machining precision, flexible production capacity, and full-process traceability. Against this backdrop, companies with cross-industry technical expertise and intelligent equipment R&D capabilities are accelerating the migration of mature automation technologies from fields such as automotive manufacturing to the medical equipment sector, driving the industry toward a new development phase characterized by technology convergence, professional compliance, and global service capabilities.

As the localization process in China’s medical device industry continues to deepen, market demand for high-end medical device core components and automated production equipment is showing rapid growth. In segments such as syringes, insulin pens, and medical consumables, the process precision and production efficiency of automated assembly equipment are continuously improving. Some leading equipment manufacturers have achieved technological breakthroughs in micron-level precision assembly, flexible production, and full-process quality control, providing solid support for high-quality large-scale production by medical companies. Meanwhile, sterile unmanned factories are gradually becoming the industry standard. Exploration of fully automated “end-to-end” production of high-end medical device core components such as CT detectors has achieved a first-pass yield of 97%, with delivery cycles significantly shortened. Industry insiders believe that as automation and AI technologies are more deeply applied in medical manufacturing, large-scale, standardized production of domestic medical devices will reach new heights, laying a solid foundation for Chinese medical equipment to enter global markets.